Needham Reiterates Buy Rating on Acadia Pharmaceuticals, Keeps $35 Target

Needham reiterated its Buy rating and $35 price target on Acadia Pharmaceuticals. The target implies 83.1% upside from the Oct. 16 close of $19.12.